首页> 外国专利> NUCLEAR SULFATED OXYSTEROL, POTENT REGULATOR OF LIPID HOMEOSTASIS, FOR THERAPY OF HYPERCHOLESTEROLEMIA, HYPERTRIGLYCERIDES, FATTY LIVER DISEASES, AND ATHEROSCLEROSIS

NUCLEAR SULFATED OXYSTEROL, POTENT REGULATOR OF LIPID HOMEOSTASIS, FOR THERAPY OF HYPERCHOLESTEROLEMIA, HYPERTRIGLYCERIDES, FATTY LIVER DISEASES, AND ATHEROSCLEROSIS

机译:核硫酸盐,脂质稳态有效调节剂,用于治疗高胆固醇血症,高甘油,脂肪肝疾病和动脉粥样硬化

摘要

The sulfated oxysterol 5-cholesten-3β, 25-diol 3-sulphate, a nuclear cholesterol metabolite that decreases lipid biosynthesis and increases cholesterol secretion and degradation, is provided as an agent to lower intracellular and serum cholesterol and/or triglycerides, and to prevent or treat lipid accumulation-associated inflammation and conditions associated with such inflammation. Methods which involve the use of this sulfated oxysterol to treat conditions associated with high cholesterol and/or high triglycerides and/or inflammation (e.g. hypercholesterolemia, hypertriglyceridemia, non-alcoholic fatty liver diseases, atherosclerosis, etc.) are also provided.
机译:提供硫酸盐的苏克斯醇5-胆固烯-3β,25-二醇3-硫酸盐,降低脂质生物合成的核胆固醇代谢物并增加胆固醇分泌和降解,以降低细胞内和血清胆固醇和/或甘油三酯,并预防或治疗脂质积累相关的炎症和与这种炎症相关的病症。还提供了涉及使用该硫酸化氧巢醇以治疗与高胆固醇和/或高甘油三酯和/或炎症(例如高胆固醇血症,高甘油三酯血症,非酒精性脂肪肝疾病,动脉粥样硬化等)的条件。

著录项

  • 公开/公告号US2021147469A1

    专利类型

  • 公开/公告日2021-05-20

    原文格式PDF

  • 申请/专利权人 VIRGINIA COMMONWEALTH UNIVERSITY;

    申请/专利号US202017060886

  • 发明设计人 SHUNLIN REN;WILLIAM M. PANDAK;

    申请日2020-10-01

  • 分类号C07J31;C07J9;A61K31/575;

  • 国家 US

  • 入库时间 2022-08-24 18:45:28

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号